Bevacizumab Plus Nab-paclitaxel and Tegafur Gimeracil Oteracil Potassium Capsule (S-1) as Second-line Treatment for Advanced Biliary Tract Cancer: a Phase Ⅱ Clinical Trial

NCT07719738 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Biliary Cancer Metastatic

Interventions

DRUG: Bevacizumab+nab-paclitaxel+tegafur gimeracil oteracil potassium capsule (S-1)

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences